` CLGN (Collplant Biotechnologies Ltd) vs S&P 500 Comparison - Alpha Spread

CLGN
vs
S&P 500

Over the past 12 months, CLGN has underperformed S&P 500, delivering a return of -56% compared to the S&P 500's +14% growth.

Stocks Performance
CLGN vs S&P 500

Loading
CLGN
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CLGN vs S&P 500

Loading
CLGN
S&P 500
Difference
www.alphaspread.com

Performance By Year
CLGN vs S&P 500

Loading
CLGN
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Collplant Biotechnologies Ltd vs Peers

S&P 500
CLGN
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Collplant Biotechnologies Ltd
Glance View

Market Cap
19.4m USD
Industry
Biotechnology

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

CLGN Intrinsic Value
7.73 USD
Undervaluation 80%
Intrinsic Value
Price
Back to Top